3 dividend shares to buy now for a 7%+ yield

Our writer is considering three dividend shares to buy for his portfolio, each of which could boost his passive income.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Close-up of British bank notes

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With inflation now topping 7%, I find the appeal of regular income from dividend shares especially strong. I have been looking for dividend shares to buy and hold in my portfolio. Here are three I would consider purchasing, each with a current dividend yield of 7% or higher.

Shares in insurer Legal & General (LSE: LGEN) have dropped 7% over the past year. Meanwhile, the company has raised its dividend. That means that the Legal & General yield is now a smidgen above 7%.

Will that continue? According to the company, there ought to be annual dividend increases in coming years. In reality, dividends are never guaranteed. Legal & General kept its dividend flat during the pandemic, but at least it did not cancel it like many competitors. But the dividend is always at risk, for example, it could be cut if new insurance pricing rules lead to lower profits.

However, I see no particular reason right now to expect that the company will not deliver on its plan to keep growing the payout. I think long-term support for dividends could come from the business’s large customer base, deep industry experience, and iconic brand. I see the share price pullback as a potential buying opportunity for my portfolio.

Imperial Brands

The tobacco maker Imperial Brands (LSE: IMB) is another income share I would consider buying for my portfolio at the moment.

The positive factors here include a yield of 8.9%, strong cash generation outlook, and a premium brand portfolio that can help support price rises without losing lots of customers. But in the long term, the tobacco market is changing. Cigarette usage is falling and non-cigarette products have so far typically been less profitable. That is a risk for Imperial, as it could hurt revenues. While pricing power can help sustain profits, if sales fall enough then profits may also fall.

That is why the company has been trying to build cigarette market shares in key countries. Its next-generation product development has met with mixed success but over time could help add new revenue streams to compensate for falling cigarette sales. Meanwhile, the company’s large cash flows help support its chunky dividend.

Jupiter Fund Management

One share I have been eyeing for my portfolio lately is fund manager Jupiter (LSE: JUP). I already own some fund and investment managers yielding more than 7%, such as Abrdn and M&G, but Jupiter’s 10% yield beats them both.

The issue here is: how sustainable is it? Like Abrdn, Jupiter has cut its dividend in recent years to make it easier to fund. But the double-digit yield suggests some investors are nervous that it may need to cut it again in future. I do see a risk of customer withdrawals leading to lower profits.

But I also see some positive aspects to the company. It has a large customer base and strong brand that could help it win new business.

Most of the slide in assets under management in the first quarter was down to negative market returns, not customers pulling out money. Indeed, in the institutional business, there was a net inflow of cash. The much larger retail and wholesale business continued to see funds flow out. But if Jupiter can keep its customers, I think profits should remain healthy. That could help support its juicy dividend.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Christopher Ruane own shares in Abrdn, Imperial Brands and M&G. The Motley Fool UK has recommended Imperial Brands and Jupiter Fund Management. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

Is the S&P 500 going to 10,000 by 2030? This expert thinks so

One stock market strategist sees animal spirits taking hold and driving the S&P 500 index even higher by the end…

Read more »